Coronavirus Update: Hungary is among the first to participate in Remdesivir clinical trials in the region
“Hungary is among the first to participate in clinical trials in the region, next to Poland,” Dr. István Vályi-Nagy said today.
During today’s Operational Group press conference, Dr. István Vályi-Nagy, Chief Physician at the South-Pest Center Hospital, spoke about the establishment of a scientific consortium under the leadership of Miklós Kásler, Minister of the Human Capacities, where the blood plasma of those who have already had the disease is currently being processed.
“Blood plasma collection and testing is underway, with more and more potential donors,” Vályi-Nagy said. “Roughly 300 potential donors who have recovered from the disease have so far been notified by Chief Medical Officer Cecília Müller, asking them to donate plasma,” he added.
Regarding the use of Remdesivir, which the US Medicines Agency has approved to treat the coronavirus, the chief physician said it is considered an effective drug, which can be used intravenously and only in a hospital. “Hungary is among the first to participate in clinical trials in the region, next to Poland,” he said.
A call center set up for advice on the coronavirus can be reached on +36-80-277-455 and +36-80-277-456 or by email email@example.com